CTRI/2016/01/006545招募中4 期
A phase IV, observational, prospective, open label, non-comparative, multicentre studyto assess the efficacy, preference, safety and tolerability of MESALO Foam (Mesalazinerectal foam 1 gm) in patients with Ulcerative Colitis
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- Cipla Ltd
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Subjects willing to give written, signed & dated informed consent for study participation.
- •2. Subjects of either gender above 18 years of age.
- •3. Subjects with established mild Ulcerative Colitis.
排除标准
- •1. Known hypersensitivity to salicylates or any of the excipients.
- •2. Severe impairment of hepatic or renal function.
- •3. Pregnant and lactating females.
- •4. Subjects who are currently participating in any other clinical
- •trial or have participated in any clinical trial in last 30 days of visit
研究者
相似试验
进行中（未招募）
不适用
A Phase IV, Open-label, Prospective Observational Study to Evaluate Virological Response in Antiretroviral-Experienced HIV-1 infected Subjects Switching to Atripla (efavirenz/emtricitabine/tenofovir DF) on an Empty Stomach - ONCE - Only Nocturnal Combination EvaluatioAntiretroviral-experienced HIV 1 infected subjects on their first and stable HAART regimen of efavirenz, emtricitabine, and tenofovir DF.MedDRA version: 9.1Level: LLTClassification code 10020192Term: HIV-1EUCTR2007-005769-36-GBGilead Sciences Limited
进行中（未招募）
1 期
Study of efficacy and safety of ranibizumab in patients with wet age related macular degeneration that have previously been treated with aflibercept.EUCTR2014-001085-10-DEovartis Pharmaceuticals UK Ltd124
进行中（未招募）
1 期
A Phase IV, prospective, open-label, uncontrolled, single-centre cohort trial to be conducted in Norway to assess the responsiveness of subjects with phenylketonuria (PKU) to treatment with Kuvan® 20 mg/kg/day for 7 days. - Response to Kuvan® in subjects with PKU from a single centre in NorwayHyperphenylalaninemia (HPA) in adults and children >=16 years of age with phenylketonuri (PKU) (classic or mild PKU, or mild hyperphenylalaninemia (HPA)).MedDRA version: 9.1Level: LLTClassification code 10034872Term: PhenylketonuriaMedDRA version: 9.1Level: LLTClassification code 10034873Term: Phenylketonuria (PKU)MedDRA version: 9.1Level: PTClassification code 10034872Term: PhenylketonuriaMedDRA version: 9.1Level: LLTClassification code 10034871Term: PhenylalaninemiaEUCTR2009-012978-12-NOMerck Serono, an affiliate of E. Merck AB
进行中（未招募）
1 期
A prospective, randomised, phase IV, open label clinical trial to study the therapeutic use of buprenorphine 20 mg (BuTrans 20µg/h) matrix transdermal patch in the management of post tonsillectomy pain in adults - PATCH TrialEUCTR2007-006117-16-GBBetsi Cadwaladr University Health Board300
已完成
不适用
PHASE IV, PROSPECTIVE, RANDOMIZED, OPEN LABEL STUDY TO EVALUATE THE EFFICACY OF AN SCHEME ONCE A DAY CONTAINING AN PROTEASE INHIBITOR AND AN SCHEME ONCE A DAY CONTAINING A NON-NUCLEOSID INHIBITOR OF THE REVERSE TRANSCRIPTASE FOR THE INITIAL TREATMENT OF INDIVIDUALS INFECTED WITH HIV-1 FROM ENVIRONMENTS WITH LIMITED RESOURCES (PEARLS)PER-070-04DIVISION DE SIDA (DADIS) E.U.A,